RadNet's DeepHealth subsidiary acquires Kheiron Medical Technologies for AI-powered diagnostic solutions
Acquiring Company
Deep Health AI India
Acquired Company
Kheiron Medical Technologies
LondonHealth CareArtificial IntelligenceBiotechnologyHealth CareArtificial IntelligenceMedicalMedical DeviceDescription
RadNet Inc.'s subsidiary, DeepHealth, has acquired London-based Kheiron Medical Technologies, a firm specializing in using deep learning AI to aid in the detection of breast cancer. This acquisition expands DeepHealth's portfolio of AI-powered diagnostic and screening solutions and enhances its capabilities to introduce breast cancer solutions in Europe.
Quick answer
Deep Health AI India is acquiring Kheiron Medical Technologies, announced October 25, 2024.
- How much did Deep Health AI India pay for Kheiron Medical Technologies?
- The deal value was not disclosed.
- What does Deep Health AI India do?
- Deep Health AI India specializes in developing advanced AI solutions for healthcare.
- Where are Deep Health AI India and Kheiron Medical Technologies based?
- Kheiron Medical Technologies is based in London, England, United Kingdom.
- Who are the decision-makers at Deep Health AI India?
- Fundz holds 1 contact at Deep Health AI India. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation (November 15, 2024)
- Flat Medical strengthens market leadership with acquisition of InjeQ assets, including FDA-Designated Breakthrough Device IQ-Tip® (September 25, 2024)
- Breeze Holdings Acquisition Corp. to merge with YD Biopharma Limited to revolutionize cancer prevention diagnostics (September 25, 2024)
- Vitalograph acquires Morgan Scientific to strengthen US commercial footprint (September 23, 2024)
- H.B. Fuller Company signs agreements to acquire Medifill Ltd. and GEM S.r.l. to expand its Medical Adhesive Technologies business (December 2, 2024)
- Medtronic completes acquisition of Fortimedix to enhance its surgical technology portfolio (November 22, 2024)
Who to call at Deep Health AI India, and when
When Deep Health AI India changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Deep Health AI India raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Deep Health AI India, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Deep Health AI India. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Deep Health AI India makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Kheiron Medical Technologies?
Kheiron Medical Technologies was acquired by Deep Health AI India. The deal was reported on October 25, 2024. Deep Health AI India specializes in developing advanced AI solutions for healthcare. The company focuses on leveraging technology to enhance medical diagnostics and patient care. Deep Health AI India is privately held and operates in Health Care.
When did Deep Health AI India acquire Kheiron Medical Technologies?
Deep Health AI India's acquisition of Kheiron Medical Technologies was reported on October 25, 2024. RadNet Inc.'s subsidiary, DeepHealth, has acquired London-based Kheiron Medical Technologies, a firm specializing in using deep learning AI to aid in the detection of breast cancer. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Kheiron Medical Technologies do?
Kheiron Medical Technologies is a London-based firm that uses deep learning AI to help radiologists detect breast cancer. It is privately held, operating in Biotechnology, and is based in London.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.